KGK Science

KGK Sciences Inc., a subsidiary company of psychedelics healthcare researcher and provider Wellbeing Digital Sciences Inc. (OTC: KONEF), has entered into a research services agreement with Halucenex Life Sciences Inc., a psychedelics subsidiary of Creso Pharma (OTC: COPHF) developing phase 2...

Mental healthcare company Wellbeing Digital Sciences Inc. (OTC: KONEF) and its subsidiary KGK Science Inc. are the founding sponsors of the Women in Psychedelics Network, also known as “WIP.”  The new project is founded and led by Wellbeing’s CEO Najla Guthrie, and it aims to...

Numinus Wellness (Pink: LKYSF) (TSXV: NUMI) announced the launch of a new clinical trial that will add information to an industry insider debate: is naturally produced psilocybin as good as synthetic psilocybin? Numinus’ new Phase I clinical trial, to be conducted in partnership...